UBS’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$28M Buy
374,358
+19,339
+5% +$1.41M 0.02% 753
2014
Q2
$24.3M Sell
355,019
-102
-0% -$6.94K 0.02% 770
2014
Q1
$24.9M Sell
355,121
-75,499
-18% -$5.25M 0.02% 674
2013
Q4
$28.8M Sell
430,620
-188,535
-30% -$11.5M 0.03% 620
2013
Q3
$32.3M Buy
619,155
+55,510
+10% +$2.82M 0.03% 495
2013
Q2
$26.6M Buy
+563,645
New +$25.7M 0.03% 524

Other funds holding CAH

UBS's CAH Position: Q3 2014 in Review

UBS increased its Cardinal Health (CAH) stake by 5.4% in Q3 2014, buying an estimated $1.41M and bringing the position to 374,358 shares worth $28M. The position accounts for 0.02% of the portfolio, ranked #753.

UBS first reported a position in CAH in Q2 2013 and has held it in 6 quarters since. The position peaked at $32.3M in Q3 2013. 643 funds tracked by Wall St. Rank hold CAH as of Q3 2014.

  • UBS held 374,358 shares of Cardinal Health worth $28M as of Q3 2014.
  • UBS bought 19,339 Cardinal Health shares in Q3 2014, an estimated $1.41M.
  • Cardinal Health made up 0.02% of UBS's portfolio in Q3 2014, its #753 holding.
  • UBS first reported a position in Cardinal Health in Q2 2013 and has held it in 6 quarters since.
  • UBS's Cardinal Health position peaked at $32.3M in Q3 2013.
  • 643 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.